The weight loss drug market, projected to hit $100 billion by the decade's end, is undergoing significant innovation. Amidst dominant players like Novo Nordisk and Eli Lilly, Amgen is emerging with MariTide, a potentially game-changing drug set to disrupt the industry. MariTide's extended-release formula promises reduced dosing frequency and sustained weight loss,...
Amgen Inc.'s shares ( NASDAQ:AMGN ) rose by 15.9% when the market opened on Friday, marking its biggest intraday rise since July 2009. The company has emerged as a potential competitor to Eli Lilly & Co. and Novo Nordisk A/S, which currently dominate the weight-loss market. Demand for anti-obesity drugs like Zepbound and Wegovy is so strong that Intelligence's...
Reasons for bullish bias: - Price bounced from support - Weekly bullish candle closing at support - 0.5 fib retracement Entry Level (CMP): 278.40 Stop Loss Level: 264.03 Take Profit Level 1: 292.77 Take Profit Level 2: 307.14 Take Profit Level 3: Open
Reasons for bullish bias: - Price bounced from strong support along with 0.382 fib retracement - Price respected trendline - Strong bullish candles Entry Level(CMP): 291.29 Stop Loss Level: 279.64 Take Profit Level 1: 302.94 Take Profit Level 2: Open
If you haven`t sold AMGN ahead of the HZNP buyout: Then analyzing the options chain and the chart patterns of AMGN Amgen prior to the earnings report this week, I would consider purchasing the $322.5 strike price Calls with an expiration date of 2024-2-9, for a premium of approximately $6.60. If these options prove to be profitable prior to the earnings...
If you haven`t sold AMGN on the HZNP deal: Then analyzing the options chain and the chart patterns of AMGN Amgen prior to the earnings report this week, I would consider purchasing the 262.5usd strike price Puts with an expiration date of 2023-11-17, for a premium of approximately $8.15. If these options prove to be profitable prior to the earnings release, I...
Amgen / AMGN is having an incredible price jump on a 1day MACD Buy Cross. Inside this long term Channel Up pattern, the stock isn't unfamiliar at all with such explosive legs upwards as the same move happened in August 4th/7th/8th. It is a clear wedge consolidation into aggressive expansion pattern. All supported by the 1day MA50. It is not too late to buy and...
Amgen Inc (AMGN) broke above the quick Bull Flag pattern and is targeting the top of the Channel Down pattern at 277.00. Based on the 1D MACD, this is a symmetrical bullish sequence as the one that peaked in early November. That will be a major test for the uptrend as the longer the price stays high, the easier it will form a 1D Golden Cross, the first since...
On this chart the price is in a clear rising channel: lower band is acting as support and upper band is acting as resistance. At this time the price is going down, but it's still in the mid of the range. So the best thing to do is to wait for the price to hit the support in order to enter a long position. Target/take profit is displayed on the chart (295,87)
AMGN Amgen to buy HZNP Horizon Therapeutics for about $27.8 billion. This huge spend could trigger a selloff in AMGN Amgen stock after earnings. It`s speculative, but looking at the AMGN Amgen options chain ahead of earnings , I would buy the $240 strike price Puts with 2023-2-17 expiration date for about $2.75 premium. If the options turn out to be profitable...
Amgen Inc. has been trending up since December last year. We can observe that price has recently reached a higher high at the resistance level of 258.00. Therefore, we are only looking for buy entries for this stock. 258.00 is a very strong resistance level; we can see from the past that prices have rejected more than 9 times from this level. After rejections,...
Sellers have been present in Amgen , keeping this stock under the 240 zone since FEB's pop. Lot of dark pool and call option flow showing bullish signs as the stock continues consolidating and eating away supply. I think the bulls win here, alarm it for $240 as a good long idea. I'm in a starter JAN 275c looking to add more positions upon breakout...
Immediate targets 211, 200,186. Invalidation at 279. We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent to suggest, are nothing more than mere fractally evident and therefore statistically likely...
Interesting compare to the crash off in money supply velocity to Amgen’s delayed bull run Maybe something to do with their business model. Also compares to money supply and seems to correlate with increase in money supply dollars finding their new homes as we can see as the money supply velocity drops off drastically.
I have changed up how to best display projected movement. In the case of AMGN triggered a SELL on my RSI algorithm on March 19, 2021. Equities nearly always obey the signal and move down, but sometimes it may continue to move up first. I have placed two red boxes and two green boxes on the chart. The larger red box depicts all of the historical movement, from a...
As we have predicted, the Amgen stock has decreased and entered the green box between $242.09 - $223.78. From here, we expect the stock to jump over $276.69. For this primary scenario, we have calculated a probability of 68%. In order not to endanger this scenario, the price needs to stay above $218.97. Below that mark, there is a 32% chance of a further drop all...
Amgen se dedica a descubrir, desarrollar, fabricar y ofrecer terapias humanas en todo el mundo. Se centra en las áreas de inflamación, oncología / hematología, salud ósea, enfermedades cardiovasculares, nefrología y neurociencia. La compañía tuvo una reacción positiva a inicios de mes cuando presentó una actualización de su fármaco para la psoriasis,...
AMGEN, D1: Support zone + Side of Bollinger bands + Hammer